Publications
Updates on the Biological Heterogeneity of Mantle Cell Lymphoma
Andrew Ip 1,2,*,† , Maciej Kabat 3,† , Lindsay Fogel 1,4 , Hassan Alkhatatneh 5 , Jason Voss 2, Amolika Gupta 4,6,Alexandra Della Pia 2
February 27, 2025 11:27 am
Read More »
Publications
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantationfor Myeloid Malignancies
The research addresses the challenge of disease relapse, a primary cause of treatment failure post-hematopoietic stem cell transplantation. By employing next-generation sequencing of cfDNA to monitor donor cell chimerism and minimal residual disease (MRD) early after transplantation, the study identifies patients at increased risk of relapse. This approach allows for potential early intervention with consolidation therapy, aiming to mitigate the risk of treatment failure.
February 13, 2025 11:51 am
7th Annual Hematologic Malignancies Symposium and Genomics Workshop
The 7th Annual Hematologic Malignancies Symposium and Genomics Workshop offers a unique opportunity for healthcare professionals to deepen their understanding of cutting-edge research and clinical advancements in
January 8, 2025 10:51 am
Innovation
ASH 24 Posters
GTC presented abstracts at ASH 2024 GTC’s posters from 2024 Convention of American Society of Hematology are now available to be downloaded. Please reach out
December 10, 2024 11:39 am
Publications
Liquid biopsy for evaluating mutations & chromosomal aberrations in CSF from patients with primary or metastatic CNS tumors
Just published in The Journal of Liquid Biopsy Liquid biopsy for evaluating mutations and chromosomal aberrations in cerebrospinal fluid from patients with primary or metastatic
December 10, 2024 10:04 am
Innovation
Genomic Testing Cooperative Unveils “GTC Interpret”, a Groundbreaking Web-Based Platform for Partner Labs to Access Analyzed Sequencing Data and Finalize Reports
Lake Forest, CA – November 13, 2024 – Genomic Testing Cooperative (GTC), a leader in advanced genomic testing, announced the launch of GTC Interpret, a
November 13, 2024 4:00 am
Publications
Expanding the Clinical Utility of Liquid Biopsy by Using Liquid Transcriptome and Artificial Intelligence
Maher Albitar, Ahmad Charifa, Sally Agersborg, Andrew Pecora, Andrew Ip, Andre Goy Abstract: Most of the current utilization of liquid biopsy (LBx) is based on
October 22, 2024 11:35 am
Article
BioAI and Genomic Testing Cooperative Announce Strategic Collaboration to Provide AI-Powered Digital Pathology Solutions for Clinical Research and Diagnostic Applications
Manchester, NH – June 25, 2024 – BioAI, an emerging biotech company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, announced a strategic collaboration with Genomic Testing Cooperative (GTC), a leading provider of molecular diagnostics for solid tumors and hematologic malignancies. This collaboration leverages the AI capabilities of both companies to deliver innovative solutions that meet the needs of pharmaceutical companies and clinicians, ultimately enhancing patient care in oncology. GTC will become an early technology access member of BioAI’s global ecosystem of clinical laboratories.
June 25, 2024 5:05 am
Publications
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy
New publication in New England Journal of Medicine for Genomic Testing Cooperative (GTC). GTC work was in collaboration with Dana-Faber cancer Institute/Harvard Medical School, Georgetown
June 12, 2024 2:05 pm
Publications
Bringing Value to Health Care
New Paper in Journal of Clinical Pathways GTC has participated in a new paper titled: Bringing Value to Health Care. Read the paper as it
June 11, 2024 11:37 am